Masimo (NASDAQ:MASI) Releases Earnings Results, Beats Estimates By $0.38 EPS

Masimo (NASDAQ:MASI) issued its quarterly earnings data on Tuesday. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38, Zacks reports. Masimo had a net margin of 3.85% and a return on equity of 14.98%.

Masimo Stock Down 0.7 %

Shares of MASI stock traded down $1.18 on Tuesday, hitting $169.54. The stock had a trading volume of 684,585 shares, compared to its average volume of 484,055. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The business has a 50 day moving average of $172.65 and a 200 day moving average of $152.54. Masimo has a 12-month low of $101.61 and a 12-month high of $184.51. The stock has a market cap of $9.08 billion, a price-to-earnings ratio of 116.92 and a beta of 1.02.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Wells Fargo & Company increased their price target on Masimo from $171.00 to $193.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $190.00 price objective (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Piper Sandler increased their price objective on shares of Masimo from $180.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday, January 22nd. Finally, Raymond James increased their price target on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.